Modified factor VII anticoagulant proteins

Details Modified factor VII anticoagulant proteins Modified factor VII anticoagulant proteins

1993-11-12

1998-10-20

Prouty, Rebecca E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

435212, 435226, 4351723, 530384, 424 9464, C07K 14745, A61K 3836, A61K 3848, C12N 964

Patent

active

058246398

ABSTRACT:
Factor VII of the coagulation cascade is modified to act as an anticoagulant. Amino acid modifications are employed to produce a modified Factor VII having a substantially reduced susceptibility to activation by enzymes which typically activate wild-type Factor VII. The modified Factor VII is able to compete with wild-type Factor VII and/or VIIa for binding tissue factor, inhibiting clotting activity. As the modified Factor VII acts specifically to interrupt the coagulation cascade, pharmaceutical compositions of modified Factor VII may be administered in place of, or in conjunction with lower doses of, conventional anticoagulant therapies.

REFERENCES:
patent: 4775624 (1988-10-01), Bang et al.
patent: 4784950 (1988-11-01), Hagen et al.
patent: 4959318 (1990-09-01), Foster et al.
patent: 4994371 (1991-02-01), Davie et al.
Kisiel et al., "Activation of Bovine Factor VII (Proconvertin) by Factor XIIa (Activated Hageman Factor)", Biochem. 16:4189-4194 (1977).
Petersen et al., "Isolation and N-terminal Amino Acid Sequence of Protein Z, a .gamma.-Carboxyglutamic Acid Containing Protein From Bovine Plasma", FEBS Lett. 114:278-282 (Jun., 1980).
McRae et al., "Mapping the Active Sites of Bovine Thrombin, Factor IXa, Factor Xa, Factor XIa, Factor XIIa, Plasma Kallikrein, and Trypsin with Amino Acid and Peptide Thioesters: Development of New Sensitive Substrates", Biochem. 20:7196-7206 (1981).
Kurachi et al., "Isolation and Characterization of a cDNA Coding for Human Factor IX", Proc. Natl. Acad. Sci. USA 79:6461-6464 (Nov., 1982).
Lottenberg et al., "The Action of Thrombin on Peptide p-Nitroanilide Substrates: Hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by Human .alpha. and .gamma.and Bovine.gamma. and .beta.-Thrombins", Thromb. Res. 28:313-332 (1982).
Hojrup et al., "Amino-Acid Sequence of the Vitamin-K-Dependent Part of Protein Z", Eur. J. Biochem. 126:343-348 (1982).
Degen et al., "Characterization of the Complementary Deoxyribonucleic Acid and Gene Coding for Human Prothrombin", Am. Chem. Soc. 22:2087-2097 (1983).
Lee et al., "An Effect of Predilution on Potency Assays of Factor VII Concentrates", Thomb. Res 30:511-519 (1983).
Broze et al., "Human Protein Z", J. Clin. Invest. 73:933-938 (Apr., 1984).
Leytus et al., "Characterization of a cDNA Coding for Human Factor X", Proc. Natl. Acad. Sci. USA 81:3699-3702 (Jun., 1984).
Cho et al., "Active-Site Mapping of Bovine and Human Blood Coagulation Serine Proteases Using Synthetic Peptide 4-Nitroanilide and Thio Ester Substrates", Biochem. 23:644-650 (1984).
Foster et al., "The Nucleotide Sequence of the Gene for Human Protein C", Proc. Natl. Acad. Sci. USA 82:4673-4677 (Jul., 1985).
Hagen et al., "Characterization of a cDNA Coding for Human Factor VII", Proc. Natl. Acad. Sci. USA 83:2412-2416 (Apr., 1986).
Leytus et al., "Gene for Human Factor X: A Blood Coagulation Factor Whose Gene Organization is Essentially Identical with that of Factor IX and Protein C", Biochem. 25:5098-5102 (1986).
Foster et al., "Propeptide of Human Protein C is Necessary for .gamma.-Carboxylation" Biochem. 26:7003-7011 (1987).
Pittman et al., "Proteolytic Requirements for Thrombin Activation and Anti-hemophilic Factor (Factor VIII)", Proc. Natl. Acad. Sci. USA 85:2429-2433 (Apr., 1988).
Takeya et al., "Bovine Factor VII, Its Purification and Complete Amino Acid Sequence", J. Biol. Chem. 263:14868-14872 (Oct., 1988).
Thim et al., "Amino Acid Sequence and Postranslational Modifications of Human Factor VIIa from Plasma and Transfected Baby Hamster Kidney Cells", Biochem, 27:7785-7793 (1988).
Sakai et al., "Binding of Human Factors VII and VIIa to a Human Bladder Carcinoma Cell Line (J82)", J. Biol. Chem. 264:9980-9988 (Jun., 1989).

Affiliated with

Also associated with

Rating

Modified factor VII anticoagulant proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified factor VII anticoagulant proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified factor VII anticoagulant proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-244255